State Street Corp Legend Biotech Corp Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Legend Biotech Corp stock. As of the latest transaction made, State Street Corp holds 1,120,293 shares of LEGN stock, worth $37.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,120,293

Previous 1,140,222 1.75%

Holding current value

$37.4 Million

Previous $55.6 Million 34.39%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$32.49 - $50.28 $647,493 - $1 Million	-19,929 Reduced 1.75%	1,120,293 $36.5 Million
Q3 2024 Nov 14, 2024	BUY	$43.55 - $59.88 $206,209 - $283,531	4,735 Added 0.42%	1,140,222 $55.6 Million
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $3.46 Million - $5.01 Million	87,485 Added 8.35%	1,135,487 $50.3 Million
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $619,810 - $787,877	11,257 Added 1.09%	1,048,002 $58.8 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $9.8 Million - $11.9 Million	171,159 Added 19.77%	1,036,745 $62.4 Million
Q3 2023 Nov 14, 2023	SELL	$63.16 - $76.5 $1.83 Million - $2.22 Million	-28,969 Reduced 3.24%	865,586 $58.1 Million
Q2 2023 Aug 14, 2023	SELL	$46.28 - $75.01 $2.08 Million - $3.37 Million	-44,895 Reduced 4.78%	894,555 $61.8 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $6.04 Million - $7.98 Million	139,077 Added 17.38%	939,450 $45.3 Million
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $1.34 Million - $1.92 Million	34,548 Added 4.51%	800,373 $40 Million
Q3 2022 Nov 15, 2022	BUY	$38.15 - $57.1 $2.21 Million - $3.31 Million	58,042 Added 8.2%	765,825 $31.2 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $853,156 - $1.4 Million	25,437 Added 3.73%	707,783 $38.9 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $843,061 - $1.31 Million	27,178 Added 4.15%	682,346 $24.8 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $22.3 Million - $30.9 Million	543,026 Added 484.23%	655,168 $30.5 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $147,560 - $211,290	4,179 Added 3.87%	112,142 $5.67 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $442,521 - $704,775	17,152 Added 18.89%	107,963 $4.43 Million
Q1 2021 May 17, 2021	BUY	$23.55 - $32.4 $203,236 - $279,612	8,630 Added 10.5%	90,811 $2.64 Million
Q4 2020 Feb 16, 2021	BUY	$25.8 - $32.39 $2.12 Million - $2.66 Million	82,181 New	82,181 $2.31 Million

Others Institutions Holding LEGN

# of Institutions

229

Shares Held

85.5M

Call Options Held

260K

Put Options Held

318K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.59B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Legend Biotech Corp Transaction History